China Said to Tighten Scrutiny of Corporate Spin-offs
SingTao · 2 SOURCESabout 2 hours ago2 MIN
Summary
Chinese regulators are reportedly intensifying their review of listed companies' plans to spin off businesses for separate listings in mainland China and Hong Kong. The reported policy direction aims to stop companies from listing their most profitable core operations separately and could be formalised in guidance as early as early next year.
Key Points
- Bloomberg, cited by both reports, said people familiar with the matter indicated regulators are strengthening scrutiny of spin-off listing plans by listed companies.
- The China Securities Regulatory Commission is said to want to curb cases where companies spin off their core and most profitable businesses, citing fairness concerns for parent-company shareholders.
- Regulators also want the spun-off business to differ from the parent company's operations, to reduce business overlap and related-party transactions.
- The tighter review has already begun for spin-off applications involving both mainland Chinese and Hong Kong markets, according to the cited sources.
- Formal guidance could be introduced as early as early next year, although discussions are continuing and the final details may still change.
- Examples cited include Goertek ending a plan to spin off Goertek Microelectronics for a Hong Kong listing, Dongcheng Pharmaceutical halting a Hong Kong spin-off, and Zhejiang Shuanghuan Driveline shelving an A-share robotics listing
Why It Matters
For Hong Kong readers, the reported move could affect one of the market's established IPO channels by making spin-off listings harder to complete. If the guidance is introduced in its reported form, companies with overlapping businesses or plans involving key profit engines may face a tougher path to listing in Hong Kong.